Zobrazeno 1 - 10
of 224
pro vyhledávání: '"oligodendrocyte precursors"'
Autor:
Florent Marguet, Mélanie Brosolo, Gaëlle Friocourt, Fanny Sauvestre, Pascale Marcorelles, Céline Lesueur, Stéphane Marret, Bruno J. Gonzalez, Annie Laquerrière
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-14 (2022)
Abstract Prenatal alcohol exposure is a major cause of neurobehavioral disabilities. MRI studies in humans have shown that alcohol is associated with white matter microstructural anomalies but these studies focused on myelin abnormalities only after
Externí odkaz:
https://doaj.org/article/c6fe454e7389405893008d9f46d22ed9
Autor:
Yat-Ping Tsui, Guy Lam, Kenneth Lap-Kei Wu, Maximilian Tak-Sui Li, Kin-Wai Tam, Daisy Kwok-Yan Shum, Ying-Shing Chan
Publikováno v:
Cells, Vol 10, Iss 8, p 2166 (2021)
Transplantation of oligodendrocyte precursors (OPs) is potentially therapeutic for myelin disorders but a safe and accessible cell source remains to be identified. Here we report a two-step protocol for derivation of highly enriched populations of OP
Externí odkaz:
https://doaj.org/article/0281f6d650d84877874b6c905c102304
Publikováno v:
Biology Open, Vol 4, Iss 8, Pp 980-992 (2015)
Myelin regeneration can occur in the brain following demyelination. Parenchymal oligodendrocyte progenitors (pOPC) are known to play a crucial role in this process. Neural stem cells (NSC) residing in the ventricular-subventricular zone (V-SVZ) also
Externí odkaz:
https://doaj.org/article/6c0e5057641a4f63b1ec260407d28620
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulises Gómez-Pinedo, Maria Salomé Sirerol-Piquer, María Durán-Moreno, José Manuel García-Verdugo, Jorge Matias-Guiu
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
BackgroundAlexander disease (AxD) is a rare disease caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP). The disease is characterized by presence of GFAP aggregates in the cytoplasm of astrocytes and loss of myelin.Objecti
Externí odkaz:
https://doaj.org/article/52d1eaca91fd449989ff617ffce8b9a1
Autor:
Marina Khodanovich, Anna Pishchelko, Valentina Glazacheva, Edgar Pan, Andrey Akulov, Mikhail Svetlik, Yana Tyumentseva, Tatyana Anan’ina, Vasily Yarnykh
Publikováno v:
Cells, Vol 8, Iss 10, p 1204 (2019)
Macromolecular proton fraction (MPF) has been established as a quantitative clinically-targeted MRI myelin biomarker based on recent demyelination studies. This study aimed to assess the capability of MPF to quantify remyelination using the murine cu
Externí odkaz:
https://doaj.org/article/a092ef99cbcd43d18477116dca86b23c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tepavčević, V., Blakemore, W. F.
Publikováno v:
Philosophical Transactions: Biological Sciences, 2005 Sep . 360(1461), 1775-1795.
Externí odkaz:
https://www.jstor.org/stable/30041383
Publikováno v:
Frontiers in Pediatrics, Vol 2 (2015)
White matter disease in preterm infants comes along with focal destructions or with diffuse myelination disturbance. Recent experimental work with transgenic mice paves the way for a unifying molecular model for both types of brain injury, placing ox
Externí odkaz:
https://doaj.org/article/6f301002450746f1b0b1ed830c93ca43
Autor:
YS Chan, Guy Lam, Maximilian Tak-Sui Li, Daisy K.Y. Shum, Kenneth Lap-Kei Wu, KW Tam, Yat-Ping Tsui
Publikováno v:
Cells
Cells, Vol 10, Iss 2166, p 2166 (2021)
Volume 10
Issue 8
Cells, Vol 10, Iss 2166, p 2166 (2021)
Volume 10
Issue 8
Transplantation of oligodendrocyte precursors (OPs) is potentially therapeutic for myelin disorders but a safe and accessible cell source remains to be identified. Here we report a two-step protocol for derivation of highly enriched populations of OP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826ba506d77267c409866799671e3a24
http://europepmc.org/articles/PMC8391516
http://europepmc.org/articles/PMC8391516